Global Nebulizer Device Pipeline Study 2019: Analysis of Devices under Development, Companies, Developments and Outlook
Dublin, Aug. 09, 2019 (GLOBE NEWSWIRE) -- The "Nebulizer Device Pipeline Study- Analysis of Devices under Development, Companies, Developments and Outlook" report has been added to ResearchAndMarkets.com's offering.
The global Nebulizer industry is estimated to be around $0.9 billion in 2019.
The 2019 Nebulizer pipeline is characterized by presence of 8 companies, actively assessing their devices. In particular, 6 companies are assessing their products in clinical phase. Currently, Aeon Research & Technology and Vincent Medical Holdings Ltd companies have their products approval phase of development.
Global Nebulizer pipeline research report presents comprehensive analysis of devices in pipeline as of June 2019. Devices in various stages of development including Pre-clinical, clinical and approval process are provided in the report. For each device, details of Company, Geography, Development Phase, Device Class, Description, Technology/platform and disease details are provided.
Clinical trial details of each Nebulizer pipeline candidate are presented including trial status, trial duration, progress, participants, location and other details.
Collaborations form an important part of global Nebulizer market. Large companies continue to collaborate with or acquire smaller players to expand their product portfolio. The current report analyzes all major companies investing and developing Nebulizer pipeline. Details of companies, their Nebulizer operations and contact information are provided.
The global Nebulizer market news and developments together with their impact on industry are also analyzed in the report.
Key Topics Covered:
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Executive Summary
2.1 Nebulizer- Device Overview
2.2 Pipeline Snapshot, 2019
2.2.1 Nebulizer Devices under Development by Phase
2.2.2 Nebulizer Devices under Development by Location
2.2.3 Nebulizer Devices under Development by Company
2.2.4 Nebulizer Devices under Development by Device Class
3 Nebulizer Clinical Pipeline Analysis
3.1 Ablynx NV Company Overview
3.2 Ablynx NV Nebulizer Device Details- Device Name, Company Name, Phase, Device Class, Description, Function and Technology
3.3 AFT Pharmaceuticals Ltd Company Overview
3.4 AFT Pharmaceuticals Ltd Nebulizer Device Details- Device Name, Company Name, Phase, Device Class, Description, Function and Technology
3.5 Aura Medical Nebican Company Overview
3.6 Aura Medical Nebican Nebulizer Device Details- Device Name, Company Name, Phase, Device Class, Description, Function and Technology
3.7 Parion Sciences Inc Company Overview
3.8 Parion Sciences Inc Nebulizer Device Details- Device Name, Company Name, Phase, Device Class, Description, Function and Technology
3.9 SolAeroMed Inc Company Overview
3.10 SolAeroMed Inc Nebulizer Device Details - Device Name, Company Name, Phase, Device Class, Description, Function and Technology
3.11 Verona Pharma Plc Company Overview
3.12 Verona Pharma Plc Nebulizer Device Details- Device Name, Company Name, Phase, Device Class, Description, Function and Technology
4 Nebulizer In Approval Process Pipeline Analysis
4.1 Aeon Research & Technology Company Overview
4.2 Aeon Research & Technology Nebulizer Device Details- Device Name, Company Name, Phase, Device Class, Description, Function and Technology
4.3 Vincent Medical Holdings Ltd Company Overview
4.4 Vincent Medical Holdings Ltd Nebulizer Device Details- Device Name, Company Name, Phase, Device Class, Description, Function and Technology
5. Latest Nebulizer News and Deals
Companies Mentioned
- Ablynx NV
- Aeon Research & Technology
- AFT Pharmaceuticals Ltd
- Aura Medical Nebican
- Parion Sciences Inc
- SolAeroMed Inc
- Verona Pharma Plc
- Vincent Medical Holdings Ltd
For more information about this report visit https://www.researchandmarkets.com/r/37go41
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
![](https://www.einpresswire.com/tracking/article.gif?t=2&a=yeVQFqJamWQ0fNXK&i=cku_di1Sil2EOu4C)